Abstract
Based on the findings in ISSVD and IFCPC terminology systems, we explored a Diagnosis Flow Draft (DFD) for observers with different experience levels on the detection of vulvar disease.
Introduction
Diagnosing vulvar diseases presents a significant clinical challenge, as it requires expertise spanning gynecology, dermatology, and pathology. Currently, clinicians rely on two primary systems: the International Society for the Study of Vulvovaginal Disease (ISSVD) system, which focuses on pathophysiology, and the International Federation for Cervical Pathology and Colposcopy (IFCPC) system, which emphasizes colposcopic patterns. However, neither provides a standardized visual "decision tree" for real-time examinations. This study introduces a Diagnosis Flow Draft (DFD) designed to bridge this gap by ranking clinical findings based on their "Overall Diagnostic Value" (ODV), providing a data-driven visual hierarchy for diagnosis.
Methodology
This retrospective study analyzed 1,068 patients (5,340 qualified images) from the Obstetrics and Gynecology Hospital of Fudan University between 2020 and 2022. The research pipeline involved:
- Evaluation: Images were assessed using both 2011 ISSVD and 2011 IFCPC terminologies.
- Metric Calculation: Sensitivity, specificity, and the Youden Index were calculated for various clinical findings (e.g., atypical vessels, papules).
- ODV Scoring: A custom "Overall Diagnostic Value" score was developed to identify pathognomonic visual cues.
- DFD Construction: Findings were mapped into a visual flowchart where arrow thickness and brightness indicate the strength of diagnostic direction.
- Validation: Nine observers with varying experience levels tested the DFD against histopathological gold standards.
Results and Clinical Insights
The study identified 15 distinct types of vulvar diseases. Key demographic and clinical characteristics were mapped to provide a comprehensive overview of the patient population.
One of the most striking findings was the high correlation between specific conditions. For instance, 83.3% of patients with vulvar Paget’s disease also presented with concurrent cervical or vaginal intraepithelial neoplasia (CIN/VaIN), suggesting that a Paget’s diagnosis should prompt immediate lower genital tract screening.
The DFD achieved a 68.8% agreement rate with histopathology, significantly outperforming the ISSVD (63.5%) and IFCPC (65.1%) systems alone (p=0.028). Crucially, the DFD effectively "democratized" expertise; there was no statistically significant difference in accuracy between experts with over 10 years of experience (68.8%) and novices with under 5 years (65.4%).
Discussion
The DFD provides a robust framework for standardized vulvar examination, particularly by using visual weight to guide clinicians through a "possible disease diagnosis order." By identifying the "Top Five" visual findings for each disease—such as "atypical vessels" for Squamous Cell Carcinoma (SCC)—the tool simplifies complex diagnostic decisions.
While the DFD shows promise in leveling the playing field for junior clinicians, the authors note that visual assessment remains inherently subjective. Future work will focus on integrating the DFD with adjunct technologies, such as artificial intelligence and fluorescence labeling, to further refine diagnostic precision and reduce human error in vulvar disease detection.
Reference: Zhou, Q., et al. (2024). "Application of a diagnosis flow draft based on appearance impression for detection of vulvar disease." Diagnosis, 11(2), 151–163. https://doi.org/10.1515/dx-2023-0146
Summary updated